Close

Valeant Pharma (VRX) to Sell Obagi Medical Products Business to Haitong for $190M

July 17, 2017 7:01 AM EDT Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that certain affiliates of the Company have entered into an agreement to sell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login